Entera Bio Ltd (ENTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 181 | 0 | 134 | 571 | 365 |
| Cost of Goods | 172 | N/A | 101 | 373 | 300 |
| Gross Profit | 9 | N/A | 33 | 198 | 65 |
| Operating Expenses | 9,766 | 8,891 | 13,151 | 12,788 | 11,533 |
| Operating Income | -9,585 | -8,891 | -13,017 | -12,217 | -11,168 |
| Other Income | 58 | 31 | 83 | -29 | -28 |
| Pre-tax Income | -9,527 | -8,860 | -12,934 | -12,246 | -11,196 |
| Income Tax | 14 | 29 | 137 | -59 | 20 |
| Net Income Continuous | -9,541 | -8,889 | -13,071 | -12,187 | -11,216 |
| Net Income | $-9,541 | $-8,889 | $-13,071 | $-12,187 | $-11,216 |
| EPS Basic Total Ops | -0.25 | -0.31 | -0.45 | -0.47 | -0.67 |
| EPS Basic Continuous Ops | -0.25 | -0.31 | -0.45 | -0.47 | -0.61 |
| EPS Diluted Total Ops | -0.25 | -0.31 | -0.45 | -0.47 | -0.67 |
| EPS Diluted Continuous Ops | -0.25 | -0.31 | -0.45 | -0.47 | -0.61 |
| EPS Diluted Before Non-Recurring Items | -0.25 | -0.31 | -0.45 | -0.47 | -0.55 |
| EBITDA(a) | $-9,539 | $-8,835 | $-12,953 | $-12,164 | $-11,105 |